Adolescent and young adult cancer survivors use exercise and social support to cope with stress, revealing insights for ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq ® (atezolizumab) and Tecentriq Hybreza ® ...
Magda Szubanski’s books are not conventional celebrity memoirs. She doesn’t name-drop or frame her story as one of triumph.
PRISM-TAMP is evaluating the approved chemotherapy gemcitabine delivered through RenovoRx's Trans-Arterial Micro-Perfusion (TAMP) platform, enabled by RenovoCath, as neoadjuvant treatment before ...
UH's busiest suburban cancer hub just got bigger — more infusion chairs, a new CT simulator, and faster scheduling for Orange ...
A Q&A with Dennis Black, PhD, professor of epidemiology and biostatistics at UCSF, who co-led a 13-year research project behind a landmark decision by the FDA that's accelerating drug development for ...
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...
AutoNation celebrated the 10th anniversary of DRV PNK and more than $50 million raised and donated to drive out cancer with a ...
University Hospitals Minoff Health Center at Chagrin Highlands in Orange has completed a nearly $10 million expansion to ...
The vaccine, called SurVaxM, aims to prevent the recurrence of glioblastoma, an aggressive brain cancer with few major advances in treatment.
A recent study has found that one in eight cancer cases worldwide in 2024 were attributable to preventable or treatable infections.
LYON, France - A new study reveals that an estimated 2.3 million new cancer cases worldwide in 2024 – about 12% of all new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results